Scientifc Laboratory Supplies (SLS) Launches a comprehensive range of products aimed at companies welcoming employees back after the lockdown has been eased. As the government releases more guidelines on how employers and their employees should prepare for the return to work, SLS appreciates there will be increased apprehension about the health and well-being of staff due to the COVID-19 pandemic....
Thermo Fisher Scientific Inc., the world leader in serving science, has announced it has received a contract from the U.S. government to provide highly specialized viral transport media (VTM) for COVID-19 sample collection. The VTM is used during collection of patient samples for proper transport to laboratories that can test for the presence of the virus....
The Coronavirus Pandemic has now reached millions of cases globally. The race is on to develop a vaccine, countries are ramping up testing, and companies are committing resources to the development of test kits. Worldwide Glass Resources® has joined the effort by allocating capacity and manufacturing custom engineered vials for Covid 19 kits....
Conversations on face mask efficacy and supply for frontline workers and the general public have been heated topics amid the Covid-19 pandemic. As the first in a series of monthly “Pandemic Response Catalyst Conversations,” three leading scientific experts will provide facts and data-driven insights on the current global mask supply, filtration properties of masks and a preview of technological innovations improving masks...
By combining Mologic’s independently verified COVID-19 lateral flow test with BioSure’s market-leading design, the companies have created a self-test for COVID-19 that can be used without any training being required. The innovative design has been proven to be extremely easy to use, requires only a fraction of a drop of blood and gives the user their own result in just 10 minutes...
Dr Laura Moro-Martin, freelance medical writer at Kolabtree, the freelance platform for scientists, explores the effects of COVID-19 on maternal health. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to escalate worldwide, with Europe and the USA now the epicentres of the pandemic. As of May 1, there are over three million declared cases and almost 240,000 deaths globally, with many countries undergoing community transmission....
HALIX B.V. has joined a consortium of partners under the guidance of the University of Oxford, to provide GMP manufacturing services supporting the large scale production of a COVID-19 vaccine (ChAdOx1 nCoV-19), being developed by the University’s Jenner Institute. This GMP manufacturing scale-up is taking place alongside early phase clinical trials. The trials are crucial in testing whether the vaccine is proven to be effective....
The Lighthouse Laboratory in Glasgow – a major new COVID-19 testing facility based in Scotland – is now operational. The Lighthouse Lab, which officially started testing samples for COVID-19 this week, is part of what will be the biggest network of diagnostic testing facilities in British history, alongside other Lighthouse Lab sites in Milton Keynes and Alderley Park, which were opened in recent days....
Thermo Fisher Scientific Inc., has announced that the U.S. Food and Drug Administration (FDA) has further expanded emergency use authorization (EUA) for its multiplex real-time PCR test intended for the qualitative detection of nucleic acid from SARS?CoV?2, the virus that causes COVID-19. "Increasing COVID-19 testing is a top priority in re-opening global economies," said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific....
Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA)1 for its new Elecsys® Anti-SARS-CoV-2 antibody test. The test is designed to help determine if a patient has been exposed to the SARS-CoV-2 virus and if the patient has developed antibodies against SARS-CoV-2. Roche has already started shipping the new antibody test to leading laboratories globally and will ramp up production capacity to high double-digit millions per month....
Data scientists from UK-headquartered AI precision medicine company, PrecisionLife, have used the Company’s proprietary AI enabled precision medicine platform to identify 59 repurposing drug candidates that could be used to develop new therapeutic strategies to increase the survival rate of patients who develop sepsis while suffering from severe COVID-19. The new study, released on Biorxiv sought to identify genetic risk factors for sepsis especially in the context of COVID-19, and to use these insights to identify existing....
A group of researchers based at Rothamsted Research have responded to a request from the White House, Microsoft, Mark Zuckerberg and others to find a way to rapidly sift through the mountain of COVID-19 scientific data. Taking time off from their own research, the Rothamsted team repurposed a tool they had originally developed to help crop scientists, to provide medical researchers with quick and intuitive access to all documented linkages between genes, medicines, and the virus....
The newly launched Version 2 Verification Panel, and Reference Material Kit, offer expanded genome coverage over the products first launched in March to now include the S gene region. As testing priorities shift from molecular to serological, LGC SeraCare also plans to expand their product offering to antibody controls in continued support of public health efforts against COVID-19. LGC SeraCare’s proprietary AccuPlex technology mimics wild-type pathogenic viruses, but is safe, non-infectious, and replication deficient...
Hamilton Company and Zymo Research Corporation have announced that the MagEx STARlet assay ready workstation is now available pre-scripted with the Quick-DNA/RNA™ Viral MagBead Kit protocol to extract pure DNA/RNA from the novel coronavirus, SARS-CoV-2. The jointly developed automated solution offers significant advantages compared to manual processing of samples via traditional time-consuming methods such as spin columns....
U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company) Anti-SARS-CoV-2 ELISA (IgG) serology test. Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA for the detection of antibodies of the immunoglobulin class G....
Analysis work from the MRC-University of Glasgow Centre for Virus Research provides evidence that SARS-CoV-2, the virus that causes COVID-19, has not mutated into different types. Recent research had suggested that more than one type of SARS-CoV-2 was now circulating in the pandemic, with one strain being more aggressive and causing more serious illness than the other. Now, using analysis of SARS-CoV-2 virus samples from the pandemic, scientists have been able to show that only one type of the virus is currently circulating....
The Liverpool Good Clinical Practice Laboratory (GCPLab) Facility directed by Professor Bill Greenhalf, has a crucial role in supporting the International Severe Acute Respiratory and Emerging Infection Consortium - Coronavirus Clinical Characterisation Consortium (ISARIC-4C) run the Clinical Characterisation Protocol UK (CCP-UK) led by Professor Calum Semple in Liverpool, Dr Kenneth Baillie in Edinburgh and Professor Peter Openshaw at Imperial College London....
To accelerate national, multi-institutional efforts focused on mapping coronavirus transmission and epidemiological studies, Thermo Fisher Scientific announces the SARS-CoV-2 GlobalAccess Sequencing Program for research consortia and industry groups battling the spread of the pandemic globally. Under the program, the company will provide 50 units of the Ion Torrent Genexus System at a subsidized price to support global collaborative COVID-19 research....
BIOHIT Healthcare Ltd is now distributing test kits for the diagnosis of both current and past COVID-19 infections to help in the fight against coronavirus in the UK. The new product line includes the MutaPLEX® Coronavirus kit from Immundiagnostik AG (IDK) – a real-time RT-PCR assay to screen for infected individuals – and Epitope Diagnostics Inc's (EDI's) immunodiagnostic tests for IgM and IgGCOVID-19 antibodies, to detect past infections....
The University of Oxford has announced an agreement with the UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate currently being trialled by the University. The partnership is to begin immediately with the final terms being agreed in the coming weeks. This will allow for rapid vaccination around the world if the COVID-19 vaccine candidate proves to be effective....
Gilson has consolidated tools, technology, services and resources to help scientists ramp up testing capabilities or study the SARS-COV-2 virus. Their new PCR FOCUS Fluid News Brochure highlights their world-renown manual and automated sample prep technologies suitable for COVID-19 diagnostics and research. For such situations when protection, speed of analysis, reliability and traceability are paramount, Gilsons range of lab equipment and instruments can deliver verifiable data and confidence in results.
Fully inclusive and managed RBDS uses Bioquell’s 35% hydrogen peroxide vapour solution to eliminate pathogens, providing a 6-log sporicidal kill. With the number of COVID-19 cases rising globally, Bioquell, a leading manufacturer of high-performance bio-decontamination systems, is offering a proven solution to help eradicate coronavirus in a range of healthcare, life sciences and pharmaceutical environments, including isolation rooms and public spaces....
Scientifc Laboratory Supplies (SLS) Launches a comprehensive range of products aimed at companies welcoming employees back after the lockdown has been eased. As the government releases more guidelines on how employers and their employees should prepare for the return to work, SLS appreciates there will be increased apprehension about the health and well-being of staff due to the COVID-19 pandemic....
Thermo Fisher Scientific Inc., the world leader in serving science, has announced it has received a contract from the U.S. government to provide highly specialized viral transport media (VTM) for COVID-19 sample collection. The VTM is used during collection of patient samples for proper transport to laboratories that can test for the presence of the virus....
The Coronavirus Pandemic has now reached millions of cases globally. The race is on to develop a vaccine, countries are ramping up testing, and companies are committing resources to the development of test kits. Worldwide Glass Resources® has joined the effort by allocating capacity and manufacturing custom engineered vials for Covid 19 kits....
Conversations on face mask efficacy and supply for frontline workers and the general public have been heated topics amid the Covid-19 pandemic. As the first in a series of monthly “Pandemic Response Catalyst Conversations,” three leading scientific experts will provide facts and data-driven insights on the current global mask supply, filtration properties of masks and a preview of technological innovations improving masks...
By combining Mologic’s independently verified COVID-19 lateral flow test with BioSure’s market-leading design, the companies have created a self-test for COVID-19 that can be used without any training being required. The innovative design has been proven to be extremely easy to use, requires only a fraction of a drop of blood and gives the user their own result in just 10 minutes...
Dr Laura Moro-Martin, freelance medical writer at Kolabtree, the freelance platform for scientists, explores the effects of COVID-19 on maternal health. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to escalate worldwide, with Europe and the USA now the epicentres of the pandemic. As of May 1, there are over three million declared cases and almost 240,000 deaths globally, with many countries undergoing community transmission....
HALIX B.V. has joined a consortium of partners under the guidance of the University of Oxford, to provide GMP manufacturing services supporting the large scale production of a COVID-19 vaccine (ChAdOx1 nCoV-19), being developed by the University’s Jenner Institute. This GMP manufacturing scale-up is taking place alongside early phase clinical trials. The trials are crucial in testing whether the vaccine is proven to be effective....
The Lighthouse Laboratory in Glasgow – a major new COVID-19 testing facility based in Scotland – is now operational. The Lighthouse Lab, which officially started testing samples for COVID-19 this week, is part of what will be the biggest network of diagnostic testing facilities in British history, alongside other Lighthouse Lab sites in Milton Keynes and Alderley Park, which were opened in recent days....
Thermo Fisher Scientific Inc., has announced that the U.S. Food and Drug Administration (FDA) has further expanded emergency use authorization (EUA) for its multiplex real-time PCR test intended for the qualitative detection of nucleic acid from SARS?CoV?2, the virus that causes COVID-19. "Increasing COVID-19 testing is a top priority in re-opening global economies," said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific....
Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA)1 for its new Elecsys® Anti-SARS-CoV-2 antibody test. The test is designed to help determine if a patient has been exposed to the SARS-CoV-2 virus and if the patient has developed antibodies against SARS-CoV-2. Roche has already started shipping the new antibody test to leading laboratories globally and will ramp up production capacity to high double-digit millions per month....
Data scientists from UK-headquartered AI precision medicine company, PrecisionLife, have used the Company’s proprietary AI enabled precision medicine platform to identify 59 repurposing drug candidates that could be used to develop new therapeutic strategies to increase the survival rate of patients who develop sepsis while suffering from severe COVID-19. The new study, released on Biorxiv sought to identify genetic risk factors for sepsis especially in the context of COVID-19, and to use these insights to identify existing....
A group of researchers based at Rothamsted Research have responded to a request from the White House, Microsoft, Mark Zuckerberg and others to find a way to rapidly sift through the mountain of COVID-19 scientific data. Taking time off from their own research, the Rothamsted team repurposed a tool they had originally developed to help crop scientists, to provide medical researchers with quick and intuitive access to all documented linkages between genes, medicines, and the virus....
The newly launched Version 2 Verification Panel, and Reference Material Kit, offer expanded genome coverage over the products first launched in March to now include the S gene region. As testing priorities shift from molecular to serological, LGC SeraCare also plans to expand their product offering to antibody controls in continued support of public health efforts against COVID-19. LGC SeraCare’s proprietary AccuPlex technology mimics wild-type pathogenic viruses, but is safe, non-infectious, and replication deficient...
Hamilton Company and Zymo Research Corporation have announced that the MagEx STARlet assay ready workstation is now available pre-scripted with the Quick-DNA/RNA™ Viral MagBead Kit protocol to extract pure DNA/RNA from the novel coronavirus, SARS-CoV-2. The jointly developed automated solution offers significant advantages compared to manual processing of samples via traditional time-consuming methods such as spin columns....
U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company) Anti-SARS-CoV-2 ELISA (IgG) serology test. Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA for the detection of antibodies of the immunoglobulin class G....
Analysis work from the MRC-University of Glasgow Centre for Virus Research provides evidence that SARS-CoV-2, the virus that causes COVID-19, has not mutated into different types. Recent research had suggested that more than one type of SARS-CoV-2 was now circulating in the pandemic, with one strain being more aggressive and causing more serious illness than the other. Now, using analysis of SARS-CoV-2 virus samples from the pandemic, scientists have been able to show that only one type of the virus is currently circulating....
The Liverpool Good Clinical Practice Laboratory (GCPLab) Facility directed by Professor Bill Greenhalf, has a crucial role in supporting the International Severe Acute Respiratory and Emerging Infection Consortium - Coronavirus Clinical Characterisation Consortium (ISARIC-4C) run the Clinical Characterisation Protocol UK (CCP-UK) led by Professor Calum Semple in Liverpool, Dr Kenneth Baillie in Edinburgh and Professor Peter Openshaw at Imperial College London....
BIOHIT Healthcare Ltd is now distributing test kits for the diagnosis of both current and past COVID-19 infections to help in the fight against coronavirus in the UK. The new product line includes the MutaPLEX® Coronavirus kit from Immundiagnostik AG (IDK) – a real-time RT-PCR assay to screen for infected individuals – and Epitope Diagnostics Inc's (EDI's) immunodiagnostic tests for IgM and IgGCOVID-19 antibodies, to detect past infections....
The University of Oxford has announced an agreement with the UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate currently being trialled by the University. The partnership is to begin immediately with the final terms being agreed in the coming weeks. This will allow for rapid vaccination around the world if the COVID-19 vaccine candidate proves to be effective....
Gilson has consolidated tools, technology, services and resources to help scientists ramp up testing capabilities or study the SARS-COV-2 virus. Their new PCR FOCUS Fluid News Brochure highlights their world-renown manual and automated sample prep technologies suitable for COVID-19 diagnostics and research. For such situations when protection, speed of analysis, reliability and traceability are paramount, Gilsons range of lab equipment and instruments can deliver verifiable data and confidence in results.
Fully inclusive and managed RBDS uses Bioquell’s 35% hydrogen peroxide vapour solution to eliminate pathogens, providing a 6-log sporicidal kill.